• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞腺瘤中 HNF1A 体细胞突变的谱与 MODY3 患者不同,提示存在遗传毒性损伤。

Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage.

机构信息

Institut National de Santé et de Recherche Médicale, U674, Génomique Fonctionnelle des Tumeurs Solides, Paris, France.

出版信息

Diabetes. 2010 Jul;59(7):1836-44. doi: 10.2337/db09-1819. Epub 2010 Apr 14.

DOI:10.2337/db09-1819
PMID:20393147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2889786/
Abstract

OBJECTIVE

Maturity onset diabetes of the young type 3 (MODY3) is a consequence of heterozygous germline mutation in HNF1A. A subtype of hepatocellular adenoma (HCA) is also caused by biallelic somatic HNF1A mutations (H-HCA), and rare HCA may be related to MODY3. To better understand a relationship between the development of MODY3 and HCA, we compared both germline and somatic spectra of HNF1A mutations.

RESEARCH DESIGN AND METHODS

We compared 151 somatic HNF1A mutations in HCA with 364 germline mutations described in MODY3. We searched for genotoxic and oxidative stress features in HCA and surrounding liver tissue.

RESULTS

A spectrum of HNF1A somatic mutations significantly differed from the germline changes in MODY3. In HCA, we identified a specific hot spot at codon 206, nonsense and frameshift mutations mainly in the NH(2)-terminal part, and almost all amino acid substitutions were restricted to the POU-H domain. The high frequency of G-to-T tranversions, predominantly found on the nontranscribed DNA strand, suggested a genotoxic mechanism. However, no features of oxidative stress were observed in the nontumor liver tissue. Finally, in a few MODY3 patients with HNF1A germline mutation leading to amino acid substitutions outside the POU-H domain, we identified a different subtype of HCA either with a gp130 and/or CTNNB1 activating mutation.

CONCLUSIONS

Germline HNF1A mutations could be associated with different molecular subtypes of HCA. H-HCA showed mutations profoundly inactivating hepatocyte nuclear factor-1alpha function; they are associated with a genotoxic signature suggesting a specific toxicant exposure that could be associated with genetic predisposition.

摘要

目的

年轻起病的成年型糖尿病 3 型(MODY3)是由 HNF1A 种系突变引起的。肝细胞腺瘤(HCA)的一个亚型也是由双等位基因体细胞 HNF1A 突变(H-HCA)引起的,而罕见的 HCA 可能与 MODY3 有关。为了更好地了解 MODY3 和 HCA 的发展之间的关系,我们比较了 HNF1A 突变的种系和体细胞谱。

研究设计和方法

我们比较了 151 例 HCA 中的体细胞 HNF1A 突变与 364 例 MODY3 中描述的种系突变。我们在 HCA 和周围肝组织中寻找遗传毒性和氧化应激特征。

结果

HNF1A 体细胞突变谱与 MODY3 的种系变化明显不同。在 HCA 中,我们在密码子 206 处发现了一个特定的热点,无义和移码突变主要发生在 NH2-末端,几乎所有的氨基酸取代都局限于 POU-H 结构域。高频率的 G-to-T 颠换,主要发生在非转录 DNA 链上,提示存在遗传毒性机制。然而,在非肿瘤肝组织中未观察到氧化应激特征。最后,在少数 MODY3 患者中,HNF1A 种系突变导致 POU-H 结构域外的氨基酸取代,我们鉴定出 HCA 的不同亚型,存在 gp130 和/或 CTNNB1 激活突变。

结论

种系 HNF1A 突变可能与 HCA 的不同分子亚型相关。H-HCA 显示出严重失活肝细胞核因子-1alpha 功能的突变;它们与遗传毒性特征相关,提示存在特定的毒物暴露,这可能与遗传易感性有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6bb/2889786/338193811792/zdb0071061850004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6bb/2889786/edb0efb90241/zdb0071061850001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6bb/2889786/ccf06bc73d0a/zdb0071061850002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6bb/2889786/dc28df5c6a65/zdb0071061850003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6bb/2889786/338193811792/zdb0071061850004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6bb/2889786/edb0efb90241/zdb0071061850001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6bb/2889786/ccf06bc73d0a/zdb0071061850002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6bb/2889786/dc28df5c6a65/zdb0071061850003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6bb/2889786/338193811792/zdb0071061850004.jpg

相似文献

1
Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage.肝细胞腺瘤中 HNF1A 体细胞突变的谱与 MODY3 患者不同,提示存在遗传毒性损伤。
Diabetes. 2010 Jul;59(7):1836-44. doi: 10.2337/db09-1819. Epub 2010 Apr 14.
2
Primary hepatocellular adenoma due to biallelic HNF1A mutations and its co-occurrence with MODY 3: case-report and review of the literature.双等位基因HNF1A突变所致原发性肝细胞腺瘤及其与青少年发病的成年型糖尿病3型的共现:病例报告及文献复习
Endocrine. 2020 Mar;67(3):544-551. doi: 10.1007/s12020-019-02138-x. Epub 2019 Nov 21.
3
Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation.MODY3 家系中伴有新型 HNF1A 种系突变的原发性肝细胞肿瘤。
J Hepatol. 2013 Oct;59(4):904-7. doi: 10.1016/j.jhep.2013.05.024. Epub 2013 May 23.
4
Diagnosis of hepatocellular adenoma in men before onset of diabetes in HNF1A-MODY: Watch out for winkers.男性在发生 HNF1A-MODY 相关糖尿病前的肝细胞腺瘤的诊断:小心眨眼。
Liver Int. 2019 Nov;39(11):2042-2045. doi: 10.1111/liv.14235. Epub 2019 Sep 13.
5
The spectrum of HNF1A gene mutations in Greek patients with MODY3: relative frequency and identification of seven novel germline mutations.希腊 MODY3 患者中 HNF1A 基因突变谱:相对频率及七种新种系突变的鉴定。
Pediatr Diabetes. 2013 Nov;14(7):526-34. doi: 10.1111/pedi.12032. Epub 2013 Mar 21.
6
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.糖原贮积病Ⅰ型患者肝细胞腺瘤的分子特征。
J Hepatol. 2013 Feb;58(2):350-7. doi: 10.1016/j.jhep.2012.09.030. Epub 2012 Oct 6.
7
Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series.年轻起病的成人型糖尿病 1 型(HNF1A-MODY)患者的肝腺瘤病:法国系列的临床、放射学和病理学特征。
J Diabetes. 2020 Jan;12(1):48-57. doi: 10.1111/1753-0407.12959. Epub 2019 Jul 10.
8
Hepatocellular Adenoma: Report of 2 Cases That Highlight the Relevance of Phenotype-Genotype Correlation in the Pediatric Population.肝细胞腺瘤:2 例病例报告强调了表型-基因型相关性在儿科人群中的相关性。
Pediatr Dev Pathol. 2023 Jul-Aug;26(4):394-403. doi: 10.1177/10935266231175426. Epub 2023 Jun 19.
9
Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.肝细胞腺瘤分类:免疫组织化学与靶向突变分析的比较评估
Diagn Pathol. 2016 Mar 9;11:27. doi: 10.1186/s13000-016-0475-5.
10
Screening of HNF1A and HNF4A mutation and clinical phenotype analysis in a large cohort of Chinese patients with maturity-onset diabetes of the young.对一大组中国青少年起病的成年型糖尿病患者进行 HNF1A 和 HNF4A 突变筛查及临床表型分析。
Acta Diabetol. 2019 Mar;56(3):281-288. doi: 10.1007/s00592-018-1232-x. Epub 2018 Oct 6.

引用本文的文献

1
Genomic and Transcriptomic Profile of HNF1A-Mutated Liver Adenomas Highlights Molecular Signature and Potential Therapeutic Implications.HNF1A 突变肝腺瘤的基因组和转录组特征突出了分子特征和潜在的治疗意义。
Int J Mol Sci. 2024 Sep 29;25(19):10483. doi: 10.3390/ijms251910483.
2
Patient with a novel syndrome with multiple benign hepatic lesions and extrahepatic neoplasms.患者患有一种新的综合征,表现为多个良性肝病变和肝外肿瘤。
Clin J Gastroenterol. 2024 Apr;17(2):300-306. doi: 10.1007/s12328-023-01899-3. Epub 2023 Dec 22.
3
De novo HNF1A mutation of young maturity-onset diabetes 3 of a young girl-Case report.

本文引用的文献

1
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.频繁的框内体细胞缺失激活炎症性肝细胞肿瘤中的gp130。
Nature. 2009 Jan 8;457(7226):200-4. doi: 10.1038/nature07475. Epub 2008 Nov 19.
2
The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3.肝细胞核因子1A(HNF1A)突变的类型和位置可调节青年发病的成年型糖尿病(MODY)-3患者的糖尿病诊断年龄。
Diabetes. 2008 Feb;57(2):503-8. doi: 10.2337/db07-0859. Epub 2007 Nov 14.
3
Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
新发年轻成年起病 3 型糖尿病患者的 HNF1A 突变:病例报告。
BMC Endocr Disord. 2023 Feb 14;23(1):38. doi: 10.1186/s12902-023-01293-7.
4
Hepatic adenomatosis in a young woman with non-familial maturity-onset diabetes of the young type 3.一名患有非家族性青年型成年发病型糖尿病3型的年轻女性的肝腺瘤病
Can Liver J. 2021 Aug 9;4(3):328-331. doi: 10.3138/canlivj-2020-0010. eCollection 2021 Summer.
5
Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver.肿瘤抑制因子HNF4α/HNF1α的破坏导致肝脏肿瘤发生。
Cancers (Basel). 2021 Oct 26;13(21):5357. doi: 10.3390/cancers13215357.
6
Decreased GLUT2 and glucose uptake contribute to insulin secretion defects in MODY3/HNF1A hiPSC-derived mutant β cells.GLUT2 和葡萄糖摄取减少导致 MODY3/HNF1A 高胰岛素血症个体胰岛细胞系衍生突变β细胞胰岛素分泌缺陷。
Nat Commun. 2021 May 25;12(1):3133. doi: 10.1038/s41467-021-22843-4.
7
Molecular classification of hepatocellular adenoma: A single-center experience.肝细胞腺瘤的分子分类:单中心经验
Ann Hepatobiliary Pancreat Surg. 2019 May;23(2):109-114. doi: 10.14701/ahbps.2019.23.2.109. Epub 2019 May 31.
8
Cell-free DNA testing: future applications in gastroenterology and hepatology.游离DNA检测:在胃肠病学和肝病学中的未来应用
Therap Adv Gastroenterol. 2019 Apr 15;12:1756284819841896. doi: 10.1177/1756284819841896. eCollection 2019.
9
Hepatocellular adenoma management: advances but still a long way to go.肝细胞腺瘤的管理:虽有进展,但仍任重道远。
Hepat Oncol. 2015 Apr;2(2):171-180. doi: 10.2217/hep.14.41. Epub 2015 May 15.
10
Monogenic Diabetes in Children and Adolescents: Recognition and Treatment Options.儿童和青少年单基因糖尿病:识别与治疗选择。
Curr Diab Rep. 2018 Jun 22;18(8):58. doi: 10.1007/s11892-018-1024-2.
使用分子标记和免疫组织化学进行肝细胞腺瘤亚型分类
Hepatology. 2007 Sep;46(3):740-8. doi: 10.1002/hep.21743.
4
HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation.肝细胞核因子1α(HNF1α)失活可独立于固醇调节元件结合蛋白-1(SREBP-1)和碳水化合物反应元件结合蛋白(ChREBP)激活,促进人肝细胞腺瘤中的脂肪生成。
J Biol Chem. 2007 May 11;282(19):14437-46. doi: 10.1074/jbc.M610725200. Epub 2007 Mar 22.
5
Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma.细胞色素P450 1B1(CYP1B1)种系突变与肝细胞核因子1α突变型肝细胞腺瘤的关联。
Cancer Res. 2007 Mar 15;67(6):2611-6. doi: 10.1158/0008-5472.CAN-06-3947.
6
Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.年轻成年发病型糖尿病中编码转录因子肝细胞核因子1α(HNF1A)和4α(HNF4A)的基因突变。
Hum Mutat. 2006 Sep;27(9):854-69. doi: 10.1002/humu.20357.
7
Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes.编码肝细胞核因子-1α的TCF1基因异构体在胰腺中表现出差异表达,并确定了单基因糖尿病中突变位置与临床表型之间的关系。
Hum Mol Genet. 2006 Jul 15;15(14):2216-24. doi: 10.1093/hmg/ddl147. Epub 2006 Jun 7.
8
Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.肝细胞腺瘤的基因型-表型相关性:新分类及与肝癌的关系
Hepatology. 2006 Mar;43(3):515-24. doi: 10.1002/hep.21068.
9
Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas.肾细胞癌中的种系肝细胞核因子1α和1β突变
Hum Mol Genet. 2005 Mar 1;14(5):603-14. doi: 10.1093/hmg/ddi057. Epub 2005 Jan 13.
10
Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families.肝细胞核因子-1α基因失活:两个青年发病的成年型糖尿病(MODY)3家系中肝腺瘤病与糖尿病表型的共分离。
J Clin Endocrinol Metab. 2004 Mar;89(3):1476-80. doi: 10.1210/jc.2003-031552.